FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
-21.67%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$128M
AUM Growth
+$128M
(-23%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$1.74B
| $109M | 85.42% | 750,000 | – | – |
|
2
Novavax
NVAX
$1.21B
| $13.9M | 10.84% | 66,810 | – | – |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.29M | 2.57% | 19,100 | – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $1.5M | 1.18% | 293,759 | – | – |
|